» Articles » PMID: 29334938

Therapeutic Plasma Exchange in a Tertiary Care Center: 185 Patients Undergoing 912 Treatments - a One-year Retrospective Analysis

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2018 Jan 17
PMID 29334938
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Therapeutic plasma exchange (TPE) is increasingly used throughout the world. Although the procedure itself is fairly standardized, it is yet unknown how the underlying disease entities influence the key coordinates of the treatment.

Methods: Retrospective chart review. The treatment indications were clustered into four categories. Data are presented as median and interquartile (25-75%) range [IQR].

Results: Within 1 year, 912 TPE treatments were performed in 185 patients (90 female, 48.6%). The distribution of the treatment numbers to the pre-specified disease categories were as follows: transplantation (35.7%), neurology (31.9%), vasculitis and immunological disease (17.3%), and others including thrombotic microangiopathy (8.1%), critical care related diseases (5.4%), hematology [multiple myeloma] (1.1%), and endocrine disorders (0.5%). The calculated plasma volume was significantly higher in patients with vasculitis and immunological diseases (3984 [3433-4439] ml) as compared to patients treated for transplant related indications (3194 [2545-3658] ml; p = 0.0003) and neurological diseases (3058 [2533-3359] ml; p < 0.0001). This was mainly due to the differences in the hematocrit which was 30.5 [27.0-33.6] % in the vasculitis/immunological disease patients and 40.2 [37.5-42.9] % in the neurological patients; p < 0.0001. Interestingly, treatment time using a membrane based technology was significantly longer than TPE using a centrifugal device 135.0 [125.0-140.0] min vs. 120.0 [112.5-135.0] min. Furthermore, the relative exchanged plasma volume was significantly lower in the treatment of vasculitis and immunological diseases as compared to treatments of transplant related indications and neurological diseases.

Conclusion: Patients with low hematocrit and high body weight do not receive the minimum recommended dose of exchange volume. Centrifugal TPE allowed faster plasma exchange than membrane TPE.

Citing Articles

EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.

David S, Bode C, Stahl K Trials. 2023; 24(1):277.

PMID: 37061693 PMC: 10105400. DOI: 10.1186/s13063-023-07300-5.


Plasma exchange in the intensive care unit: a narrative review.

Bauer P, Ostermann M, Russell L, Robba C, David S, Ferreyro B Intensive Care Med. 2022; 48(10):1382-1396.

PMID: 35960275 PMC: 9372988. DOI: 10.1007/s00134-022-06793-z.


Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.

Stahl K, Wand P, Seeliger B, Wendel-Garcia P, Schmidt J, Schmidt B Crit Care. 2022; 26(1):134.

PMID: 35551628 PMC: 9097091. DOI: 10.1186/s13054-022-04003-2.


Safety and tolerability of solvent/detergent-treated plasma for pediatric patients requiring therapeutic plasma exchange: An open-label, multicenter, postmarketing study.

Josephson C, Goldstein S, Askenazi D, Cohn C, Spinella P, Metjian A Transfusion. 2021; 62(2):396-405.

PMID: 34931321 PMC: 9299645. DOI: 10.1111/trf.16775.


Regional Hypertonic Citrate Anticoagulation in Membrane Therapeutic Plasma Exchange: A Case Series.

Reis T, Ramos de Freitas G, Reis F, Cascelli de Azevedo M, Dias P, Figueiredo Santos D Can J Kidney Health Dis. 2021; 8:20543581211054736.

PMID: 34777842 PMC: 8579339. DOI: 10.1177/20543581211054736.


References
1.
Tholking G, Mesters R, Dittrich R, Pavenstadt H, Kumpers P, Reuter S . Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM). PLoS One. 2015; 10(6):e0130402. PMC: 4488284. DOI: 10.1371/journal.pone.0130402. View

2.
Hafer C, Kielstein J . Pro: High dose of therapeutic plasma exchange-mind the gap!. Nephrol Dial Transplant. 2017; 32(9):1457-1460. DOI: 10.1093/ndt/gfx084. View

3.
Cordoba J, Larrarte C, Medina M . Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessions. J Clin Apher. 2015; 30(6):347-52. DOI: 10.1002/jca.21391. View

4.
Schmitt E, Kundt G, Klinkmann H . Three years with a national apheresis registry. J Clin Apher. 1992; 7(2):58-62. DOI: 10.1002/jca.2920070204. View

5.
Arslan O, Arat M, Tek I, Ayyildiz E, Ilhan O . Therapeutic plasma exchange in a single center: Ibni Sina experience. Transfus Apher Sci. 2004; 30(3):181-4. DOI: 10.1016/j.transci.2004.02.007. View